(Q43156735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tom H. Johnston

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jonathan M. Brotchie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Jordi Gomez-Ramirez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Gaby Reyes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Philippe Huot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Susan H Fox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

86-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Management of impulse control disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Disabling repetitive behaviors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Behavioural effects of amphetamine in a small primate: Relative potencies of the d- and l-isomers

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Dopamine neurons and their role in reward mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Longitudinal outcome of Parkinson's disease patients with psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Clinical-pathological study of levodopa complications

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

A neostriatal habit learning system in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Pathological gambling caused by drugs used to treat Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Multiple daily amphetamine administration: behavioral and neurochemical alterations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Compulsive eating and weight gain related to dopamine agonist use.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Incentive-sensitization and addiction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

Role of basal ganglia in behavioral learning

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100009707

7 January 2021

10.1017/S0317167100009707

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20169779%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference